FourWorld Capital Management LLC
- SEC CIK
- 0001770525
- Latest filing
- Aug 14, 2026
ABUS holding history
Arbutus Biopharma Corp in every 13F filed by FourWorld Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −1,020,910−100.0% | Sold out | Holders |
| Q3 2025 | 1,020,910 | $4.63M | 11.2% | −205,800−16.8% | Reduced | Holders |
| Q2 2025 | 1,226,710 | $3.79M | 2.7% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,226,710 | $4.28M | 2.9% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,226,710 | $4.01M | 2.2% | −1,745,817−58.7% | Reduced | Holders |
| Q3 2024 | 2,972,527 | $11.4M | 10.6% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,972,527 | $9.19M | 12.1% | −28,000−0.9% | Reduced | Holders |
| Q1 2024 | 3,000,527 | $7.74M | 7.5% | +1,909,676+175.1% | Added | Holders |
| Q4 2023 | 1,090,851 | $2.73M | 5.0% | −251,056−18.7% | Reduced | Holders |
| Q3 2023 | 1,341,907 | $2.72M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,341,907 | $3.09M | 0.9% | −658,183−32.9% | Reduced | Holders |
| Q1 2023 | 2,000,090 | $6.06M | 3.8% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,000,090 | $4.66M | 6.7% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,000,090 | $3.82M | 7.4% | +199,090+11.1% | Added | Holders |
| Q2 2022 | 1,801,000 | $4.88M | 8.3% | +253,261+16.4% | Added | Holders |
| Q1 2022 | 1,547,739 | $4.61M | 2.9% | – | No prior filing | Holders |